LexaGene Holdings Inc. (CVE:LXG – Get Free Report) shares dropped 19.2% on Tuesday . The stock traded as low as C$0.10 and last traded at C$0.11. Approximately 2,135,377 shares traded hands during trading, an increase of 1,156% from the average daily volume of 170,061 shares. The stock had previously closed at C$0.13.
LexaGene Price Performance
The stock’s 50 day moving average is C$0.11 and its two-hundred day moving average is C$0.11. The company has a debt-to-equity ratio of 138.01, a quick ratio of 1.13 and a current ratio of 1.39. The stock has a market capitalization of C$14.77 million, a PE ratio of -1.31 and a beta of 2.26.
About LexaGene
LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
Featured Articles
- Five stocks we like better than LexaGene
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Charles Schwab Fortifies its Uptrend on EPS Beat
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Lockheed Martin Stock Aims for a Fresh All-Time High
- 10 Best Airline Stocks to Buy
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.
